CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real-world practice

Malinda T. West, Claire E. Smith, Andy Kaempf, Tia C.L. Kohs, Ramin Amirsoltani, Jessica Ribkoff, Josh Lee Choung, Alison Palumbo, Zahi Mitri, Joseph J. Shatzel

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real-world practice'. Together they form a unique fingerprint.

Medicine & Life Sciences